BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10402222)

  • 1. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
    Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
    Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
    J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
    Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
    Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats.
    Berrendero F; Romero J; García-Gil L; Suarez I; De la Cruz P; Ramos JA; Fernández-Ruiz JJ
    Biochim Biophys Acta; 1998 Sep; 1407(3):205-14. PubMed ID: 9748581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.
    Romero J; Berrendero F; Garcia-Gil L; de la Cruz P; Ramos JA; Fernández-Ruiz JJ
    Neuroscience; 1998 Jun; 84(4):1075-83. PubMed ID: 9578396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
    Sim LJ; Hampson RE; Deadwyler SA; Childers SR
    J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
    Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
    J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development.
    Berrendero F; García-Gil L; Hernández ML; Romero J; Cebeira M; de Miguel R; Ramos JA; Fernández-Ruiz JJ
    Development; 1998 Aug; 125(16):3179-88. PubMed ID: 9671590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.
    Selley DE; Rorrer WK; Breivogel CS; Zimmer AM; Zimmer A; Martin BR; Sim-Selley LJ
    J Neurochem; 2001 May; 77(4):1048-57. PubMed ID: 11359870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.
    Berrendero F; Sánchez A; Cabranes A; Puerta C; Ramos JA; García-Merino A; Fernández-Ruiz J
    Synapse; 2001 Sep; 41(3):195-202. PubMed ID: 11391780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.
    Romero J; Fernández-Ruiz JJ; Vela G; Ruiz-Gayo M; Fuentes JA; Ramos JA
    Drug Alcohol Depend; 1998 May; 50(3):241-9. PubMed ID: 9649978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels.
    Gonzalez S; Fernandez-Ruiz J; Sparpaglione V; Parolaro D; Ramos JA
    Drug Alcohol Depend; 2002 Mar; 66(1):77-84. PubMed ID: 11850139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain.
    Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Vogt LJ; Sim-Selley LJ
    J Neurochem; 1999 Dec; 73(6):2447-59. PubMed ID: 10582605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.
    Mailleux P; Vanderhaeghen JJ
    Neuroscience; 1992; 48(3):655-68. PubMed ID: 1376455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
    Rubino T; Viganò D; Costa B; Colleoni M; Parolaro D
    J Neurochem; 2000 Dec; 75(6):2478-84. PubMed ID: 11080200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
    Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
    Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice.
    Berrendero F; Mendizábal V; Murtra P; Kieffer BL; Maldonado R
    Eur J Neurosci; 2003 Oct; 18(8):2197-202. PubMed ID: 14622180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
    Wiley JL; Martin BR
    Chem Phys Lipids; 2002 Dec; 121(1-2):57-63. PubMed ID: 12505690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.